Corona Remedies shares surge 41% on listing day, debuting at a significant premium amid strong investor demand and confidence ...

Following the successful closure of its initial public offering (IPO), share allocation has been finalised and applicants can ...

Arun Kejriwal, Founder of Kejriwal Research and Investment Services, believes that the issue is expected to get benefit of ...

As per the latest update, the company’s shares are trading at Rs 1,353 in the unlisted markets. This indicates a premium of ...

The Gujarat-based pharmaceutical company develops and manufactures medicines with a focus on women's healthcare, ...

Corona Remedies’ shares made a strong debut on the stock market, gaining 36.72 per cent over its IPO price. The pharma ...

The last grey market premium (GMP) for the Corona Remedies IPO was Rs 310 on December 12. At the upper end of the price band ...

Shares of Corona Remedies are set to be listed on the Indian stock market on Monday, 15 December 2025, and the GMP shows a ...

Corona Remedies launched its IPO today to raise more than Rs 655 crore entirely through an offer for sale (OFS) of shares ...

Corona Remedies was commanding robust demand with an overall subscription of 31.59 times, while Wakefit trailed with a more ...

The company’s IPO, worth Rs 655.37 crore, is entirely an offer-for-sale of 62 lakh shares. The price band for the Corona ...

Corona Remedies IPO GMP Day 1, Subscription Status Live Updates: The initial public offering of Corona Remedies kicked off ...